• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

We Can Finally Stop Worrying About SGLT2 Inhibitors and Acute Kidney Injury.

作者信息

Sridhar Vikas S, Tuttle Katherine R, Cherney David Z I

机构信息

Toronto General Hospital Research Institute, UHN, Toronto, Canada; Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Canada.

Division of Nephrology, Department of Medicine, University of Washington, Spokane, WA.

出版信息

Am J Kidney Dis. 2020 Oct;76(4):454-456. doi: 10.1053/j.ajkd.2020.05.014. Epub 2020 Jul 22.

DOI:10.1053/j.ajkd.2020.05.014
PMID:32712014
Abstract
摘要

相似文献

1
We Can Finally Stop Worrying About SGLT2 Inhibitors and Acute Kidney Injury.我们终于可以不再担心钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂与急性肾损伤的问题了。
Am J Kidney Dis. 2020 Oct;76(4):454-456. doi: 10.1053/j.ajkd.2020.05.014. Epub 2020 Jul 22.
2
Acute Kidney Injury Events in Patients With Type 2 Diabetes Using SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs: A Retrospective Cohort Study.使用 SGLT2 抑制剂与其他降血糖药物的 2 型糖尿病患者的急性肾损伤事件：一项回顾性队列研究。
Am J Kidney Dis. 2020 Oct;76(4):471-479.e1. doi: 10.1053/j.ajkd.2020.03.019. Epub 2020 May 25.
3
Identification of risk factors associated with acute kidney injury in patients taking sodium-glucose cotransporter-2 inhibitors.服用钠-葡萄糖协同转运蛋白2抑制剂的患者中与急性肾损伤相关的危险因素的识别。
Pharmacotherapy. 2024 Mar;44(3):249-257. doi: 10.1002/phar.2902. Epub 2024 Jan 12.
4
SGLT2 inhibitors and contrast-associated acute kidney injury.钠-葡萄糖协同转运蛋白2抑制剂与造影剂相关的急性肾损伤
Kardiol Pol. 2024;82(1):5-6. doi: 10.33963/v.kp.98717. Epub 2024 Jan 17.
5
Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury?是否有确凿证据表明使用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂会导致急性肾损伤？
J Nephrol. 2023 Jan;36(1):31-43. doi: 10.1007/s40620-022-01422-w. Epub 2022 Aug 13.
6
Acute kidney injury from SGLT2 inhibitors: potential mechanisms.钠-葡萄糖协同转运蛋白2抑制剂所致急性肾损伤：潜在机制
Nat Rev Nephrol. 2016 Nov 16;12(12):711-712. doi: 10.1038/nrneph.2016.159.
7
[Severe diabetic ketoacidosis, acute kidney injury and dehydration due to canagliflozin in type 2 diabetes mellitus patient: Atypical clinical presentation].[2型糖尿病患者因卡格列净导致严重糖尿病酮症酸中毒、急性肾损伤和脱水：非典型临床表现]
Aten Primaria. 2019 Dec;51(10):664-666. doi: 10.1016/j.aprim.2019.04.007. Epub 2019 Jul 17.
8
[About the safety profile of SGLT2 inhibitors].[关于钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂的安全性概况]
Rev Med Liege. 2022 Apr;77(4):218-223.
9
SGLT2 inhibitors and the risk of contrast-induced acute kidney injury: Time for a PCI Trial?钠-葡萄糖协同转运蛋白2抑制剂与造影剂诱导的急性肾损伤风险：是时候开展一项经皮冠状动脉介入治疗试验了吗？
Kardiol Pol. 2024;82(1):3-4. doi: 10.33963/v.phj.98860. Epub 2024 Jan 17.
10
Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases.与钠-葡萄糖共转运蛋白 2 抑制剂相关的 Fournier 坏疽：自发性上市后病例回顾。
Ann Intern Med. 2019 Jun 4;170(11):764-769. doi: 10.7326/M19-0085. Epub 2019 May 7.

引用本文的文献

1
Dual-faced guardians: SGLT2 inhibitors' kidney protection and health challenges: a position statement by Kasralainy nephrology group (KANG).双面守护者：钠-葡萄糖协同转运蛋白2抑制剂的肾脏保护作用与健康挑战：卡斯拉莱尼肾脏病学组（KANG）的立场声明
Diabetol Metab Syndr. 2025 Jun 14;17(1):214. doi: 10.1186/s13098-025-01790-w.
2
The 'nephrotoxins' were stopped: what is in a name and its impact on kidney and cardiac health?“肾毒素”停用：名称中有什么及其对肾脏和心脏健康的影响？
Intern Med J. 2025 Jun;55(6):1037-1041. doi: 10.1111/imj.70060. Epub 2025 Apr 22.
3
Sodium-glucose co-transporter 2 inhibitors: Prospects for canine myxomatous mitral valve disease and finding the "right drug" and the "right dose" for dogs.
钠-葡萄糖协同转运蛋白2抑制剂：犬黏液瘤性二尖瓣疾病的前景以及为犬找到“正确的药物”和“正确的剂量”
J Vet Med Sci. 2025 Jun 1;87(6):647-666. doi: 10.1292/jvms.25-0040. Epub 2025 Apr 16.
4
Update on the Efficacy and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis.钠-葡萄糖协同转运蛋白2抑制剂在慢性病患者中的疗效和安全性最新进展：一项系统评价和荟萃分析
Medicina (Kaunas). 2025 Jan 23;61(2):202. doi: 10.3390/medicina61020202.
5
Effect of SGLT2 inhibitors on kidney function of type 2 diabetes patients during Ramadan: A systematic review.斋月期间SGLT2抑制剂对2型糖尿病患者肾功能的影响：一项系统评价
Qatar Med J. 2024 Jun 20;2024(3):26. doi: 10.5339/qmj.2024.26. eCollection 2024.
6
Applications of SGLT2 inhibitors beyond glycaemic control.SGLT2 抑制剂在血糖控制之外的应用。
Nat Rev Nephrol. 2024 Aug;20(8):513-529. doi: 10.1038/s41581-024-00836-y. Epub 2024 Apr 26.
7
Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study.钠-葡萄糖协同转运蛋白2抑制剂对心力衰竭患者利尿剂剂量影响的真实世界证据：一项回顾性队列研究。
Front Pharmacol. 2024 Apr 2;15:1366439. doi: 10.3389/fphar.2024.1366439. eCollection 2024.
8
Sotagliflozin and Kidney Outcomes, Kidney Function, and Albuminuria in Type 2 Diabetes and CKD: A Secondary Analysis of the SCORED Trial.索格列净与 2 型糖尿病和 CKD 的肾脏结局、肾功能和蛋白尿：SCORED 试验的二次分析。
Clin J Am Soc Nephrol. 2024 May 1;19(5):557-564. doi: 10.2215/CJN.0000000000000414. Epub 2024 Jan 26.
9
Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease: a systematic review and meta-analysis.钠-葡萄糖协同转运蛋白2抑制剂在慢性肾脏病患者中的疗效与安全性：一项系统评价和荟萃分析
Int Urol Nephrol. 2024 Apr;56(4):1359-1381. doi: 10.1007/s11255-023-03789-6. Epub 2023 Sep 26.
10
Optimal use of SGLT2 inhibitors in diabetic kidney transplant recipients.糖尿病肾移植受者中钠-葡萄糖协同转运蛋白2抑制剂的优化使用
Front Nephrol. 2022 Nov 10;2:1014241. doi: 10.3389/fneph.2022.1014241. eCollection 2022.